Version 3 of data for "Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway"
Posted on 2017-07-26 - 10:11
Lovastatin-lactone v. F420 in the A5UMI1 site. The Lovastatin-lactone form is shown with green sticks, and F420 with red sticks. Residues within 5 angstroms of the ligands are labeled and highlighted. Hydrophilic site residues are shown in cyan, and hydrophobic residues in grey.
CITE THIS COLLECTION
DataCite
3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
4OR
AAPG Bulletin
AAPS Open
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review
Muskal, Steven; Sliman, Joe; Kokai-Kun, John; Pimentel, Mark; Wacher, Vince; Gottlieb, Klaus (2017). Version 3 of data for "Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway". f1000research.com. Collection. https://doi.org/10.6084/m9.figshare.c.3835981.v1
or
Select your citation style and then place your mouse over the citation text to select it.
SHARE
Usage metrics
AUTHORS (6)
SM
Steven Muskal
JS
Joe Sliman
JK
John Kokai-Kun
MP
Mark Pimentel
VW
Vince Wacher
KG
Klaus Gottlieb